Aptose Biosciences Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aptose Biosciences Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Aptose Biosciences Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $112K, a 4.27% decline year-over-year.
  • Aptose Biosciences Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $461K, a 8.47% increase year-over-year.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2023 was $405K, a 25.8% decline from 2022.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2022 was $546K, a 1.62% decline from 2021.
  • Aptose Biosciences Inc. annual Operating Lease, Payments for 2021 was $555K, a 3.35% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $405K -$141K -25.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $546K -$9K -1.62% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $555K +$18K +3.35% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $537K +$66K +14% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $471K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.